Entero Healthcare Solutions shares rose sharply following the company’s acquisition of a majority equity stake in Anand Chemiceutics. The stock was trading at Rs. 1176.95 on the BSE, marking an increase of 3.54% or 40.20 points from its previous close of Rs. 1136.75.
The stock opened at Rs. 1165.05 and recorded an intraday high of Rs. 1176.95 and a low of Rs. 1142.15, with 1,377 shares changing hands during the session. Entero Healthcare is listed in the BSE group ‘B’ category with a face value of Rs. 10. It has seen a 52-week high of Rs. 1509.90 on 26 May 2025 and a 52-week low of Rs. 944.00 on 29 December 2025.
Over the past week, the stock’s highest and lowest prices were Rs. 1190.25 and Rs. 1102.70, respectively. The company’s current market capitalization stands at Rs. 5121.02 crore.
Promoters hold a majority stake of 52.42% in Entero Healthcare, while institutional investors and non-institutional investors hold 21.56% and 26.02%, respectively.
Entero Healthcare Solutions has successfully acquired a 51.51% stake in Anand Chemiceutics. The business of Anand Chemiceutics aligns closely with Entero Healthcare’s core operations, focusing on the wholesale distribution of medical devices and related products.
Entero Healthcare Solutions operates as a healthcare product distributor across India. Its technology-driven platform supports distribution services to pharmacies, hospitals, and clinics nationwide.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
